ROCHE CORLEEN M. (Chief Financial Officer) exercised options at IOVANCE BIOTHERAPEUTICS, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 8/10/2026ACC: 0001104659-26-093482
Officer· Chief Financial Officer
Since Mar 2026
-21.24K
Net shares
Net seller
$131.9K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
49.99K acquired · 71.23K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+49.99K
Price / share
—
Trade value
—
% of position
New position
8/6/2026
0.00→49.99K
Common Stock
Direct
Shares
−21.24K
Price / share
$6.21
Trade value
$131.89K
% of position
42.5%
8/6/2026
49.99K→28.76K
Total
Net shares
+28.76K
Net value
-$131.89K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/6/2026 | M · Option Exercise | +49.99K | — | — | New position | 0.00 | 49.99K |
| Common Stock Direct | 8/6/2026 | F · Tax Withholding | −21.24K | $6.21 | $131.89K | 42.5% | 49.99K | 28.76K |
| Total | +28.76K | -$131.89K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
49.99K shares
Shares
−49.99K
Strike price
Held after
100K
Exercisable
—
8/6/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock49.99K shares | 8/6/2026 | M · Option Exercise | −49.99K | — | 100K |